Susana Pichardo - Sep 7, 2022 Form 4 Insider Report for Convey Health Solutions Holdings, Inc. (CNVY)

Role
SVP, Accounting
Signature
/s/ Giovanni Castellanos, attorney-in-fact for Susana Pichardo
Stock symbol
CNVY
Transactions as of
Sep 7, 2022
Transactions value $
-$218,313
Form type
4
Date filed
9/9/2022, 09:11 PM
Previous filing
Mar 30, 2022
Next filing
Oct 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNVY Common Stock, par value $0.01 per share Exercise of in-the-money or at-the-money derivative security $332K +41.8K $7.94 41.8K Sep 7, 2022 Direct
transaction CNVY Common Stock, par value $0.01 per share Exercise of in-the-money or at-the-money derivative security $202K +29.9K +71.43% $6.76 71.7K Sep 7, 2022 Direct
transaction CNVY Common Stock, par value $0.01 per share Sale -$752K -71.7K -100% $10.50 0 Sep 7, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNVY Stock Option (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -41.8K -100% $0.00* 0 Sep 7, 2022 Common Stock, par value $0.01 per share 41.8K $7.94 Direct F2
transaction CNVY Stock Option (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -29.9K -38.46% $0.00 47.8K Sep 7, 2022 Common Stock, par value $0.01 per share 29.9K $6.76 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.49 to $10.515, inclusive. The reporting person undertakes to provide to Convey Health Solutions Holdings, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The options, together representing a right to purchase 119,416 shares, consist of (i) 59,708 time-vesting options and (ii) 59,708 performance-vesting options. Time-vesting options are subject to a five-year time-based vesting schedule, with 20% vesting on September 4, 2020 and the remainder vesting in 16 equal installments every three months thereafter. Performance-vesting options vest over a five-year performance period commencing in 2019, with 20% of the stock options eligible to vest each year of the performance period based on achievement of certain financial metrics.
F3 Exercise price reflects a reduction of $1.18 per award from original exercise price of $7.94 as part of a special dividend as previously disclosed in the Company's proxy statement for its 2022 annual meeting of stockholders.